- Fund Type: SICAV
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
Dexia Equities L - Biotechnology
+ Add to WatchlistXUJ4:GR
229.4000 EUR 2.3800 1.03%As of 14:55:13 ET on 05/24/2013.
Snapshot for Dexia Equities L - Biotechnology (XUJ4)
| Open: | 234.7900 | High - Low: | 234.7900 - 228.9010 | Primary Exchange: | Berlin |
|---|---|---|---|---|---|
| Volume: | 124 | 52-Week Range: | 156.0800 - 241.1550 | Beta vs BTK: | 0.6755 |
Fund Profile & Information for XUJ4
Dexia Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.
| Inception Date: | 2000-04-06 | Telephone: | 352-254-3431 |
|---|---|---|---|
| Managers: | RUDI VAN DEN EYNDE | ||
| Web Site: | www.dexia-am.com | ||
Fundamentals for XUJ4
| NAV | - |
|---|---|
| Assets (M) | (on 2013-05-23) 367.3552 |
| Shares out (M) | 0.00 |
| Market Cap (M) | 0.00 |
| % Premium | - |
| Average 52-Week % Premium | - |
| Fund Leveraged | N |
Dividends for XUJ4
No dividends reported
Performance for XUJ4
| 1-Month | +2.87% | 1-Year | +40.11% |
|---|---|---|---|
| 3-Month | +20.36% | 3-Year | +24.91% |
| Year To Date | +34.28% | 5-Year | +26.77% |
| Expense Ratio | 1.77 |
Top Fund Holdings for XUJ4
Filing Date: 03/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 450,000 | 22,018,500 | 7.491% |
| Amgen Inc | 196,000 | 20,091,960 | 6.836% |
| Biogen Idec Inc | 84,500 | 16,300,895 | 5.546% |
| Regeneron Pharmaceuticals Inc | 80,000 | 14,112,000 | 4.801% |
| Celgene Corp | 112,000 | 12,981,920 | 4.417% |
| Alexion Pharmaceuticals Inc | 118,000 | 10,872,520 | 3.699% |
| H Lundbeck A/S | 465,000 | 8,578,308 | 2.919% |
| Onyx Pharmaceuticals Inc | 87,000 | 7,730,820 | 2.630% |
| Ablynx NV | 805,000 | 7,039,500 | 2.395% |
| BioMarin Pharmaceutical Inc | 96,000 | 5,976,960 | 2.034% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page